Hepatocellular carcinoma (HCC) is ranked as the sixth most common cancer around the
world. With the emergence of the state-of-the-art modalities lately, such as liver …

Hepatocellular carcinoma (HCC) is among the leading causes of worldwide cancer‐related
morbidity and mortality. Poor prognosis of HCC is attributed primarily to tumor presentation …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide
and is associated with poor clinical prognosis, which is mainly caused by tumor recurrence …

Hepatocellular carcinoma (HCC) is a primary liver cancer with a huge challenge in terms of
its complex etiology and its management. The fact that the most common site of early tumor …

Hepatocellular carcinoma (HCC) is a highly malignant tumor and ranked as the fourth cause
of cancer-related mortality. The poor clinical prognosis is due to an advanced stage and …

Circulating tumor cells (CTC) and cancer stem cells (CSC) have been proposed as tools for
detection and characterization of disease and individualization of therapy in patients with …

Hepatocellular carcinoma (HCC) is the fifth most common neoplasm and a major cause of
cancer-related death worldwide. There is no ideal biomarker allowing early diagnosis of …

Serum alpha‐fetoprotein and radiologic imaging are the most commonly used tests for early
diagnosis and dynamic monitoring of treatment response in hepatocellular carcinoma …

Circulating tumor cells (CTCs) have been shown as a surrogate for cancer progression and
prognostication. We aimed to determine an association between CTCs and survival of …

Background A growing body of research indicates that the monitoring of circulating tumor
cells (CTCs) may have great significance to the diagnosis of malignant tumors, assessment …